TY - JOUR
T1 - Effect of black mulberry (Morus nigra) extract treatment on cognitive impairment and oxidative stress status of d -galactose-induced aging mice
AU - Turgut, Nergiz Hacer
AU - Mert, Derya Guliz
AU - Kara, Haki
AU - Egilmez, Hatice Reyhan
AU - Arslanbas, Emre
AU - Tepe, Bektas
AU - Gungor, Huseyin
AU - Yilmaz, Nese
AU - Tuncel, Necati Baris
N1 - Publisher Copyright:
© 2015 Taylor & Francis.
PY - 2016/6/2
Y1 - 2016/6/2
N2 - Context: Morus nigra L. (Moraceae) has various uses in traditional medicine. However, the effect of M. nigra on cognitive impairment has not been investigated yet.Objective: The objective of this study is to determine the phenolic acid content and DNA damage protection potential of M. nigra leaf extract and to investigate the extract effect on cognitive impairment and oxidative stress in aging mice.Materials and methods: Phenolic acid content was determined by quantitative chromatographic analysis. DNA damage protection potential was evaluated on pBR322 plasmid DNA. Thirty-two Balb-C mice were randomly divided into four groups (control, d-galactose, d-galactose + M. nigra 50, and d-galactose + M. nigra 100). Mice were administered d-galactose (100 mg/kg, subcutaneous) and M. nigra (50 or 100 mg/kg, orally) daily for 8 weeks. Behavioral responses were evaluated with Morris water maze. Activities of antioxidant enzymes and levels of malondialdehyde (MDA) were assayed in serum, brain, and liver.Results: In extract, vanillic (632.093 g/g) and chlorogenic acids (555.0 g/g) were determined. The extract between 0.02 and 0.05 mg/mL effectively protected all DNA bands against the hazardous effect of UV and H2O2. Morus nigra significantly improved learning dysfunctions (p < 0.01), increased memory retention (p < 0.01), reduced MDA levels (p < 0.05), and elevated SOD, GPx, and CAT activities (p < 0.05) compared with the d-galactose group.Discussion and conclusion: These results show that M. nigra has the potential in improving cognitive deficits in mice and that M. nigra may be useful to suppress aging, partially due to its scavenging activity of free radicals and high antioxidant capacity.
AB - Context: Morus nigra L. (Moraceae) has various uses in traditional medicine. However, the effect of M. nigra on cognitive impairment has not been investigated yet.Objective: The objective of this study is to determine the phenolic acid content and DNA damage protection potential of M. nigra leaf extract and to investigate the extract effect on cognitive impairment and oxidative stress in aging mice.Materials and methods: Phenolic acid content was determined by quantitative chromatographic analysis. DNA damage protection potential was evaluated on pBR322 plasmid DNA. Thirty-two Balb-C mice were randomly divided into four groups (control, d-galactose, d-galactose + M. nigra 50, and d-galactose + M. nigra 100). Mice were administered d-galactose (100 mg/kg, subcutaneous) and M. nigra (50 or 100 mg/kg, orally) daily for 8 weeks. Behavioral responses were evaluated with Morris water maze. Activities of antioxidant enzymes and levels of malondialdehyde (MDA) were assayed in serum, brain, and liver.Results: In extract, vanillic (632.093 g/g) and chlorogenic acids (555.0 g/g) were determined. The extract between 0.02 and 0.05 mg/mL effectively protected all DNA bands against the hazardous effect of UV and H2O2. Morus nigra significantly improved learning dysfunctions (p < 0.01), increased memory retention (p < 0.01), reduced MDA levels (p < 0.05), and elevated SOD, GPx, and CAT activities (p < 0.05) compared with the d-galactose group.Discussion and conclusion: These results show that M. nigra has the potential in improving cognitive deficits in mice and that M. nigra may be useful to suppress aging, partially due to its scavenging activity of free radicals and high antioxidant capacity.
KW - Antioxidant
KW - learning
KW - memory retention
KW - phenolic acid
UR - http://www.scopus.com/inward/record.url?scp=84945362998&partnerID=8YFLogxK
U2 - 10.3109/13880209.2015.1101476
DO - 10.3109/13880209.2015.1101476
M3 - Artículo
C2 - 26510817
AN - SCOPUS:84945362998
SN - 1388-0209
VL - 54
SP - 1052
EP - 1064
JO - Pharmaceutical Biology
JF - Pharmaceutical Biology
IS - 6
ER -